239 related articles for article (PubMed ID: 22633272)
1. Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis.
Lin CY; Pfluger CM; Henderson RD; McCombe PA
J Neuroimmunol; 2012 Aug; 249(1-2):93-5. PubMed ID: 22633272
[TBL] [Abstract][Full Text] [Related]
2. The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.
Wakatabi K; Komine M; Meephansan J; Matsuyama Y; Tsuda H; Tominaga S; Ohtsuki M
Eur J Dermatol; 2012; 22(3):333-6. PubMed ID: 22494834
[TBL] [Abstract][Full Text] [Related]
3. Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children.
Hamzaoui A; Berraies A; Kaabachi W; Haifa M; Ammar J; Kamel H
J Asthma; 2013 Oct; 50(8):803-9. PubMed ID: 23855553
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure.
Roth GA; Zimmermann M; Lubsczyk BA; Pilz J; Faybik P; Hetz H; Hacker S; Mangold A; Bacher A; Krenn CG; Ankersmit HJ
J Surg Res; 2010 Oct; 163(2):e79-83. PubMed ID: 20638676
[TBL] [Abstract][Full Text] [Related]
5. Soluble ST2 and IL-33: Potential markers of endometriosis in the Tunisian population.
Mbarik M; Kaabachi W; Henidi B; Sassi FH; Hamzaoui K
Immunol Lett; 2015 Jul; 166(1):1-5. PubMed ID: 25977120
[TBL] [Abstract][Full Text] [Related]
6. Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.
Ishikawa S; Shimizu M; Ueno K; Sugimoto N; Yachie A
Cytokine; 2013 May; 62(2):272-7. PubMed ID: 23561929
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor.
Li XL; Lin TT; Qi CY; Yuan L; Xia LP; Shen H; Lu J
J Investig Med; 2013 Jun; 61(5):848-51. PubMed ID: 23552178
[TBL] [Abstract][Full Text] [Related]
8. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction.
Zhang K; Zhang XC; Mi YH; Liu J
Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154
[TBL] [Abstract][Full Text] [Related]
9. High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue.
Guerrero CD; Arrieta AF; Ramirez ND; Rodríguez LS; Vega R; Bosch I; Rodríguez JA; Narváez CF; Salgado DM
Cytokine; 2013 Mar; 61(3):766-71. PubMed ID: 23357301
[TBL] [Abstract][Full Text] [Related]
10. The Interleukin 33/ST2 axis in patients with primary Sjögren syndrome: expression in serum and salivary glands, and the clinical association.
Jung SM; Lee J; Baek SY; Lee JH; Lee J; Park KS; Park SH; Kim HY; Kwok SK
J Rheumatol; 2015 Feb; 42(2):264-71. PubMed ID: 25512474
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of soluble ST2 and interleukin-33 in patients with dermatomyositis and polymyositis.
Yuan L; Yao L; Zhao L; Xia L; Shen H; Lu J
Clin Exp Rheumatol; 2013; 31(3):428-32. PubMed ID: 23485578
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of soluble urokinase plasminogen activator receptor, soluble ST2, and IL-33 in bronchopulmonary dysplasia.
Tunc T; Cekmez F; Yildirim S; Bulut O; Ince Z; Saldir M; Aydemir G; Yaman H; Coban A
Pediatr Res; 2014 Jun; 75(6):788-92. PubMed ID: 24603291
[TBL] [Abstract][Full Text] [Related]
13. IL-33/ST2 correlates with severity of haemorrhagic fever with renal syndrome and regulates the inflammatory response in Hantaan virus-infected endothelial cells.
Zhang Y; Zhang C; Zhuang R; Ma Y; Zhang Y; Yi J; Yang A; Jin B
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003514. PubMed ID: 25658420
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum interleukin-33 and soluble ST2 across early pregnancy, and their association with miscarriage.
Kaitu'u-Lino TJ; Tuohey L; Tong S
J Reprod Immunol; 2012 Sep; 95(1-2):46-9. PubMed ID: 22841163
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of IL-33 and its receptor ST2 are elevated in patients with ankylosing spondylitis.
Li GX; Wang S; Duan ZH; Zeng Z; Pan FM
Scand J Rheumatol; 2013; 42(3):226-31. PubMed ID: 23409750
[TBL] [Abstract][Full Text] [Related]
16. Serum soluble ST2 is associated with ER-positive breast cancer.
Lu DP; Zhou XY; Yao LT; Liu CG; Ma W; Jin F; Wu YF
BMC Cancer; 2014 Mar; 14():198. PubMed ID: 24636276
[TBL] [Abstract][Full Text] [Related]
17. Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren's Syndrome.
Zhao L; Yao L; Yuan L; Xia L; Shen H; Lu J
Cytokine; 2013 Oct; 64(1):22-4. PubMed ID: 23910012
[TBL] [Abstract][Full Text] [Related]
18. Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.
Kim DJ; Baek SY; Park MK; Park KS; Lee JH; Park SH; Kim HY; Kwok SK
J Korean Med Sci; 2013 Aug; 28(8):1145-53. PubMed ID: 23960440
[TBL] [Abstract][Full Text] [Related]
19. Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation.
Houghton-Triviño N; Salgado DM; Rodríguez JA; Bosch I; Castellanos JE
J Gen Virol; 2010 Mar; 91(Pt 3):697-706. PubMed ID: 19889931
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of soluble ST2 in patients with active newly diagnosed ANCA-associated vasculitis.
Hladinova Z; Hruskova Z; Svobodova B; Malickova K; Lanska V; Konopásek P; Jancova E; Rysava R; Edelstein CL; Tesar V
Mediators Inflamm; 2015; 2015():603750. PubMed ID: 25802482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
